Venue: David Intercontinental

Final Program - ILSI Biomed Israel 2008

TUESDAY, MAY 27, 2008

WEDNESDAY, MAY 28, 2008

THURSDAY, MAY 29, 2008

TUESDAY, MAY 27, 2008
07:30-08:45	SPECIAL LECTURE * Limited Seating - Medical Device Attendees Only. Pre-Registration Required Via Mail to: rmedical@kenes.com**
	Title: TBD Mr. David Cassak Managing Partner, Windhover Information Inc.; Editor, Medical Devices IN, CT, USA Sponsored by: Rainbow Medical , Ltd.

09:00-10:05	OPENING CEREMONY
	WELCOME Mr. Eli Yishai Minister of Industry, Trade and Labor, Israel Honorable Mr. Shimon Peres President of the State of Israel
10:05-10:35	KEYNOTE LECTURE
	Stem Cells and Drug Discovery Sir. Prof. Ian Wilmut Leader of the Queen's Medical Research Institute, Edinburgh, UK
10:35-11:00	Coffee Break
11:00-13:00	BREAKOUT SESSIONS
11:00-13:00	Company Presentations	Company Presentations	Lectures		Poster Session
11:00-11:20	Dr. Ehud Cohen BioControl Medical, Ltd.	Dr. David Aviezer Protalix Biotherapeutics, Inc.	11:00-12:00 Stem Cells and Cell Therapies Dr. Aharon Schwartz Vice President, Strategic Business Planning & New Ventures , Teva Pharmaceuticals, Ltd., Israel 12:00-13:00 Stem Cell and Tissue Regeneration Dr. Shulamit Levenberg Senior Lecturer, Department of Biomedical Engineering, Technion Institute, Israel		Topic: Cardiovascular Moderator: Prof. Rafael Beyar Chief Executive Officer & Director General RAMBAM Health Care Campus, Israel
11:20-11:40	Mr. Alon Kushnir Deep Breeze, Ltd.	Mr. Efi Cohen AraziCollPlant, Ltd.
11:40-12:00	Mr. Jacob Ben - Arie BetaStim, Ltd.	Mr. Avi Barak BioCancell Therapeutics, Ltd.
12:00-12:20	Mr. Raveh Gill-More BrainsGate, Ltd.	Mr. Nissim Mashiach OMRIX Biopharmaceuticals, Inc.
12:20-12:40	Mr. Yuval Yanai Given Imaging, Ltd.	Dr. Morris Laster BioLineRx, Ltd.
12:40-13:00	Mr. Ori Gal NuLens, Ltd.	Dr. Daniel Zur Quark Pharmaceuticals, Inc.
13:00-14:00	Lunch Break
14:00-14:50	KEYNOTE LECTURE
	Convergence in Health Care : Devices, Biologics, Pharma, IT, Communication & Navigation Dr. Steve Oesterle Senior Vice President for Medicine and Technology, Medtronic, MN, USA
14:50-15:15	Coffee Break
11:00-13:00	BREAKOUT SESSIONS
15:15-17:15	Company Presentations	Company Presentations	Lectures	Poster Session
15:15-15:35	Prof. Yoram Palti NovoCure, Ltd.	Prof. Pnina Fishman Can-Fite BioPharma, Ltd.	15:15-16:15 India's Biotechnology Market: Opportunities & Challenges Kiran Mazumdar-Shaw Chairman & Managing Director Biocon, Ltd., Bangalore, India 16:15-17:15 Medical Technology – What are the Current Trends; Investments, Deals and Key Success factors John L. Babitt Senior Manager Transaction Advisory Services, Ernst & Young N.Y., USA	Topic: Endocrinology Moderator: Prof. Moshe Phillip Director, Institute for Endocrinology and Diabetes National Center of Childhood Diabetes Schneider Children's Medical Center of Israel Vice Dean, Sackler School of Medicine, Tel-Aviv University, Israel
15:35-15:55	Dr. Joshua Reichert InspireMD, Ltd.	Dr. Avri Havron Modigene, Inc.
15:55-16:15	Dr. Yoav Medan InSightec, Ltd.	Dr. Ronald Ellis NasVax, Ltd.
16:15-16:35	Dr. Amit Goffer Argo Medical Technologies, Ltd	Dr. Yael Margolin Gamida Cell, Ltd.
16:35-16:55	Prof. Amir Elami CorAssist Cardiovascular, Ltd.	Dr. Mira Peled-Kamar Applied Immune Technologies (AIT), Ltd.
16:55-17:15	Ms. karen Sarid Galil Medical	Dr. Rinat Rotem-Yehudar CureTech, Ltd.
15:15-17:15	TECHNOLOGY TRANSFER SESSIONS
15:15-15:45	Yissum the Technology Transfer Company of the Hebrew University of Jerusalem Mrs. Nava Swersky Sofer President & CEO Novel Nasal Drug Delivery Prof. Elka Touitou School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, Israel An Assay and Kit and Device for Removing Amylase from Body Fluids Dr. Aharon Palmon Department of Oral Biology, Faculty of Dental Medicine, Hebrew University of Jerusalem, Israel Incensole Acetate – "A Novel Pharmacological Agent From an Ancient Drug" Mr. Arik Moussaieff Faculty of Medicine, Hebrew University of Jerusalem, Israel A New Diagnosis and Prognosis of Preeclemsia and Other Diseases Utilizing Molecular Species of VEGF Receptor Prof. Eli Keshet Department of Microbiology, Faculty of Medicine, Hebrew University of Jerusalem, Israel
15:45-16:15	Ramot at Tel Aviv University: Innovation and Excellence in Technology Transfer Dr. Yehuda Niv CEO, Ramot at Tel Aviv University Ltd, Israel Treatment Solutions for CNS Disorders from Tel Aviv University Ms. Irit Ben-Chlouch Director of Bussienss Development, Ramot at Tel Aviv University Ltd, Israel Therapuetic Approaches to Diabetes and Cardiovasculat Diseases from Tel Aviv University Dr. Tamar Raz Director of Bussienss Development, Ramot at Tel Aviv University Ltd, Israel Cancer & Drug Delivery Projects at Tel Aviv University Dr. Nissim Chen Director of Bussienss Development, Ramot at Tel Aviv University Ltd, Israel Medical Devices developed at Tel Aviv University Dr. Ze'ev Weinfeld Executive VP for Business Development, Ramot at Tel Aviv University Ltd, Israel
16:15-16:45	Technion Research and Development Foundation Dr. Benjamin Soffer Head of Business Unit, Technion, Israel
16:45-17:15	Platform Technologies Yeda R&D Co. Ltd - Technology Transfer from the Weizmann Institute of Science Mr. Amir Naiberg CEO, Yeda R&D Co. Ltd, Israel
17:15-19:30	Rad Biomed Award Ceremony
19:30	ILSI 60's Party

WEDNESDAY, MAY 28, 2008
07:30-08:45	SPECIAL LECTURE * Limited Seating - Medical Device Attendees Only. Pre-Registration Required Via Mail to: hhartson@kenes.com**
	Getting Your Medical Device to Market: Current Challenges with FDA Medical Device Regulation Speakers: Steven B. Datlof, M.D., J.D. Jonathan S. Kahan, J.D. John J. Smith, M.D., J.D. Sponsored by: Hogan & Hartson

09:00-09:50	KEYNOTE LECTURE
	GREETINGS Dr. Eli Opper Chief Scientist, Ministry of Industry, Trade and Labor, Israel Medical Device Industry - Where is it Going? Mr. Francois Maisonrouge Senior Managing Partner, Evercore Partners, NY, USA
09:50-10:35	KEYNOTE LECTURE
	Building Innovative Biotechnology Companies Mr. Barry Greene President and COO, Alnylam Pharmaceuticals, Inc., MA, USA
10:35-11:00	Coffee Break
11:00-13:00	BREAKOUT SESSIONS
11:00-13:00	Company Presentations	Company Presentations	Lectures	Poster Session
11:00-11:20	Dr. Eliezer Beeri Innovent Medical Solutions	Mr. Yehiel Tal Regentis Biomaterials, Ltd.	11:00-11:40 Engineering the Immune System: From Cancer Immunotherapy to Nano-electronics Prof. Yoram Reiter Professor of Molecular Immunology, Head, Laboratory of Molecular Immunology, Dean, Faculty of Biology, Technion Institute, Israel 11:40-12:20 The Development of Therapeutic Antibodies Dr. Aya Jakobovits Executive Vice President, Head of R&D, Agensys, Inc., CA, USA 12:20-13:00 New Horizons in Cancer Research and Treatment Dr. Robert Schwartz Senior Director, Oncology Licensing, Bristol-Myers Squibb, Inc., NJ, USA	Topic: Immunology
11:20-11:40	Mr. Itay Itzhaky NiTi Surgical Solutions, Ltd.	Mr. Amir Avniel Rosetta Genomics, Ltd.
11:40-12:00	Ms. Maital Ben-Hur Optonol, Ltd.	Dr. Itschak Lemensdorf Thrombotec, Ltd.
12:00-12:20	Mr. Avner Halperin EarlySense, Ltd.	Dr. Ofer Toledano Sol-Gel Technologies, Ltd.
12:20-12:40	Dr. Daphna Heffetz TransPharma Medical, Ltd.	Dr. Yossi Cohen Compugen, Ltd.
12:40-13:00	Mr. Yuval Ofek dbMotion, Inc.	Dr. Nir Dotan Glycominds, Ltd.
13:00-14:00	Lunch Break
13:00-14:00	SPECIAL LECTURE * Limited seating - Medical Device Attendees Only. Pre-Registration Required Via Mail to: scolb@kenes.com**
	Patents: New Rules and Their Implications Mr. Sanford T. Colb, Founder & CEO Sponsored by: Sanford T. Colb & Co., Israel
14:00-14:50	KEYNOTE LECTURE
	The US Healthcare System: Unavoidable Realities, Harsh Truths and Stark Choices Prof. George Poste Distinguished Professor of Biology, The Biodesign Institute, Arizona State University, AZ, USA
14:50-15:15	Coffee Break
15:00-17:15	BREAKOUT SESSIONS
15:15-17:15	Company Presentations	Company Presentations	Lectures	Poster Session
15:15-15:35	Mr. Udi Gordin Virtual Ports, Ltd.	Mr. Uri Danon AtoxBio, Inc.	15:15-16:05 The BioTech IT Revolution - "What Can We Do with all this Data?" Prof. Eran Segal Assistant Professor, Department of Molecular Cell Biology, Weizmann Institute of Science, Israel 16:05-17:15 "Personalized Medicine Panel- 2020" Moderator: Dr. Edward Abrahams, Executive Director of Personalized Medicine Coalition, Washington DC, USA Dr. Mara G. Aspinall President of Genzyme Genetics a Division of Genzyme, MA, USA Dr. Ralph Snyderman Chancellor, Duke University, NC, USA	Topic: Oncology
15:35-15:55	Dr. Irit Yaniv MetaCure, Ltd.	Dr. Yair Feld Genegrafts, Ltd.
15:55-16:15	Mr. Omer Barlev Paieon Medical, Ltd.	Mr. David Tsur Kamada, Ltd.
16:15-16:35	Mr. Dan Sullivan superDimension, Ltd.	Mr. Yoram Ashery NeuroSurvival Technologies (NST), Ltd.
16:35-16:55	Mr. Omer Einav Motorika Medical (Israel), Ltd.	Dr. Alex Kozak D-Pharm, Ltd.
16:55-17:15	Mr. Jacob Gabel Walk Care, Ltd.	Mr. Stephan Simes BioSante Pharmaceuticals, Inc.
17:15-18:15	Canaan Partners Symposia http://canaan.com/Biomed2008
	Building Successful Global Health Care Companies Mr. Brent Ahrens General Partner , Canaan Partners Dr. Seth Rudnick General Partner, Canaan Partners Dr. Ehud Geller Founder & Managing Partner, Medica Venture Partners, Israel Dr. Morris C. Laster CEO, BioLineRX, Israel

THURSDAY, MAY 29, 2008
09:00-09:50	PANEL – WHAT DOES PHARMA WANT?
	Moderator: Mr. Roger Longman, Managing Partner, Windhover Information Inc., CT , USA Ms. Barbara Yanni Vice President & Chief Licensing Officer, Merck & Co, Inc., NJ, USA Ms. Tamar D. Howson Executive Vice President of Business Development, Lexicon Pharmaceuticals Inc., NJ, USA Dr. Jeremy Levin Senior Vice president - External Science, Technology and Licensing, Bristol-Myers Squibb, Inc., NY, USA Dr. Arnon Rosenthal Founder & CEO, MazorX Inc,. CA, USA
09:50-10:35	KEYNOTE LECTURE
	Convergence: Bringing Together the Different Disciplines, Businesses, Skill Sets and Technologies to Create New Opportunities in Healthcare Dr. Harlan Weisman Chief Science and Technology Officer, Medical Devices & Diagnostics, Johnson & Johnson, NJ, USA
10:35-11:00	Coffee Break
11:00-13:00	BREAKOUT SESSIONS
11:00-13:00	Company Presentations	Company Presentations	Lectures	Israeli Incubators' Parade
11:00-11:20	Mr. Imad Younis Alpha Omega Engineering, Ltd.	Prof. Dror Harats Vascular Biogenics (VBL), Ltd.	11:00-12:00 Heart Failure Treatment in 2020 Prof. James E. Udelson Associate Chief, Division of Cardiology; Director, Nuclear Cardiology Laboratory; Co-Director, Hypertrophic Cardiomyopathy Center, Tufts-New England Medical Center, MA, USA 12:00-13:00 US Drug and Device Commercialization Issues Related to Coding, Coverage and Payment with both Private and Government Payers Ms. Lynn Shapiro Snyder Senior Member, Epstein Becker & Green, P.C. USA Mr. Robert E. Wanerman Senior Counsel, National Health Care and Life Sciences Practice, Epstein Becker & Green, P.C. USA	Speakers: TBD
11:20-11:40	Dr. Benny Rousso Impulse Dynamics, Inc.	Ms. Yehudit Natan Core Dynamics, Inc.
11:40-12:00	Dr. Shimon Eckhouse Syneron Medical, Ltd.	Dr. Dov Tamarkin Foamix, Ltd.
12:00-12:20	Mr. Zohar Gendler Beta-O2 Technologies, Ltd.	Dr. Tamar Tennenbaum HealOr, Ltd.
12:20-12:40	Mr. Ori Haedomi Mazor Surgical Technologies, Ltd.	Dr. Moshe Flugelman MultiGene Vascular Systems (MGVS), Ltd.
12:40-13:00	Mr. Terence Gunning Cadent, Inc.	Dr. Zeev Even Chen Dr. Oren M. Becker DermiPsor, Ltd.
13:00-14:00	Lunch Break
14:00-14:50	KEYNOTE LECTURE
	Mr. David Brennan CEO, AstraZeneca PLC, London, UK
14:50-15:15	Coffee Break
15:15-17:15	BREAKOUT SESSIONS
15:15-17:15	Company Presentations	Company Presentations	Company Presentations
15:15-15:35	Mr. Arik Avni Andante Medical Devices, Ltd.	Prof. Yaakov Naparstek ProtAb Ltd.	Dr. Liat Mintz DiaLean, Ltd.
15:35-15:55	Mr. Lior Ma'ayan OrSense, Ltd.	Mr. Yoav KahaneEnzymotec, Ltd.	Dr. Shai Yarkoni Target-In, Ltd.
15:55-16:15	Mr. Gal Cohen MediWound, Ltd.	Mr. Shlomo Dagan Andromeda Biotech, Ltd.	Prof. Simon Benita Nanolymf, Ltd.
16:15-16:35	HAPPY HOUR
16:35-18:35	The U.S. Market: Challenges and Opportunities Ahead - Perspectives from DHHS, FDA and CMS
	Moderator: Ms. Lynn Shapiro Snyder Senior Member, Epstein Becker & Green, P.C. USA
16:35-17:25	DHHS Dr. Tevi Troy Deputy Secretary Department of Health and Human Services
17:05-17:45	FDA Dr. Daniel G. Schultz Director of FDA's Center for Devices and Radiological Health, USA
17:45-18:10	CMS Ms. Leslie Norwallk Strategic Counsel to Epstein Becker & Green, P.C. USA (Served as Acting Administrator for CMS under the Bush Administration)
18:10-18:35	Panel Discussion